EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes - Full Text View

Sponsored by:	Sanofi-Aventis
Information provided by:	Sanofi-Aventis
ClinicalTrials.gov Identifier:	NCT00272532

Purpose

Study objective:

To demonstrate, in patients with myofascial pain syndrome in cervical region, the degree of efficacy of thiocolchicoside ointment administered to trigger point regions compared with the trigger point injection.

Condition	Intervention	Phase
Myofascial Pain Syndromes	Drug: Thiocolchicoside	Phase IV

MedlinePlus related topics: Fibromyalgia

Drug Information available for: Thiocolchicoside

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	The Efficacy of Topical Thiocolchicoside in Cervical Myofascial Pain Syndrome: Triple-Arm, Single-Blind, Randomized, Prospective, Phase IV Clinical Study

Further study details as provided by Sanofi-Aventis:

Primary Outcome Measures:

Pain relief (Visual Analog Scale and sensitometer) and increase in mobility of neck. Patient and physician satisfaction

Estimated Enrollment:	65
Study Start Date:	April 2005

Eligibility

Criteria

Inclusion Criteria:

Submitted to clinic with a complaint of head and neck pain
Be diagnosed as having myofascial pain syndrome by determining the active trigger points in trapezius and/or interscapular region according to criteria of Simons and Travel
Have 1 to 8 active trigger point(s)

Exclusion Criteria:

Have evident cervical discopathy and signs of osteoarthritis
Have bleeding diathesis or using anticoagulant medication which hinders injection
Have known malignity, being used steroids, have immunodepressive disorders and/or being taken immunodepressive drugs
Be pregnant or have the possibility of being pregnant or not being used a regular contraceptive method
Have known allergic reaction against Thiocolchicoside

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00272532

Locations

Sponsors and Collaborators

Sanofi-Aventis

Investigators

Study Director:

Edibe Taylan

Sanofi-Aventis

More Information

clinicalstudyresults.org This link exits the ClinicalTrials.gov site

Study ID Numbers:	L_9892
Study First Received:	January 4, 2006
Last Updated:	February 18, 2008
ClinicalTrials.gov Identifier:	NCT00272532
Health Authority:	Turkey: Ministry of Health

Study placed in the following topic categories:

Muscular Diseases
Neuromuscular Diseases
Musculoskeletal Diseases
Myofascial Pain Syndromes

Fibromyalgia
Pain
Rheumatic Diseases

Additional relevant MeSH terms:

Pathologic Processes
Disease
Syndrome
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009